Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENO1P3 is a pseudogene related to the ENO1 gene. Pseudogenes are non-functional copies of genes that have lost their ability to produce functional proteins through evolutionary processes. They are typically not considered therapeutic targets because they do not encode functional proteins. The search results mention that "several pseudogenes have been identified, including one on the long arm of chromosome 1" in relation to ENO1, but pseudogenes themselves are not therapeutic targets[2][4][6][7]. If you were intending to ask about ENO1 (the functional protein), that would be a legitimate therapeutic target with extensive biological functions in glycolysis, tumor progression, and immune regulation. ENO1 is indeed considered a promising therapeutic target and prognostic biomarker, particularly in cancer research[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ENO1P3.